You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

Global AIDS, TB and Malaria Fund Facing Massive Shortfall in Funding: The US Has Given $200 Million Out of a Requested $3.5 Billion Per Year

Listen
Media Options
Listen

Related

    While the pharmaceutical industry has spent hundreds of millions of dollars on advertising, lobbying, and political campaign contributions in the last few years, a new Congressional study has found that the Global Fund to Fight AIDS, TB and Malaria is threatened by a lack of money.

    The study by the General Accounting Office reports the fund does not have enough money to fund more than a small number of programs.

    The director of the fund told a congressional committee yesterday it will to raise more than $1 billion very soon if it hopes to support all the worthy applications for grants it expects this year.

    The Global Fund to Fight AIDS, TB and Malaria was created by the United Nations and the G8 group of industrialized nations in 2001. AIDS, TB and malaria kill a total of 6 million people a year around the world. Over 5,000 people die of AIDS every day in Africa alone. 3,000 African children die every day of malaria.

    The fund had asked for $3.5 billion a year from the United States. The US gave $200 million last year and Bush’s plan would add $200 million a year.

    • Dr. Paul Zeitz, Executive Director, Global AIDS Alliance.
    • Adrienne Germain, president, International Women’s Health Coalition.

    Related links:

    Related Story

    StoryNov 21, 2024Despite White House Pressure, 19 U.S. Senators Back Bernie Sanders’s Bills to Block Arms Sales to Israel
    The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

    Non-commercial news needs your support

    We rely on contributions from our viewers and listeners to do our work.
    Please do your part today.
    Make a donation
    Top